The mixed substituent cyclophosphazene monomers N3P3Cl4(OCHCH2)(OCH2CF3) (2) and N3P3Cl3(OCHCH2) (OCH2CF3)2 (3) undergo polymerization under radical initiation conditions to yield the mixed substituent poly[(vinyloxy)cyclotriphosphazenes] [CH2CH(ON3P3Cl4(OCH2CF3))]n(5) and [CH2CH(ON3P3Cl3(OCH2CF3)2)]n (6), respectively. A significant, progressive reduction in molecular weight compared to the parent polymer of the series [CH2CH(ON3P3Cl5)]n (4) was observed and attributed to increased chain transfer. The thermal decomposition of 5 and 6 is similar to that observed for 4 with an exothermic elimination of HCl at modest temperatures. An alternative synthetic pathway involving nucleophilic substitution reactions of 4 provided [CH2CH(ON3P3(OCH2CF3)5)]n (7), [CH2CH(N3P3Cl2(OC6H5)3)]n (8A), [CH2CH(ON3P3Cl1.7(OC6H5)3.3)]n (8B), [CH2CH(ON3P3Cl1.5(NHCH3)3.5)]n (9), [CH2CH(ON3P3Cl3.8 (N(CH2CH3)2)1.2]n (10A), [CH2CH(ON3P3Cl3.4(N(CH2CH3)2)1.6)]n (10B), and [N3P3Cl2(OCHCH2)(N(CH3)2)]n, (11). The thermal behaviors of all of the new polymers were examined by TGA, DTA, DSC, and pyrolysis mass spectrometry.
No takes yet. Share an insight, caveat, or question.
Carter et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: